Skip to main content

Table 4 Motor outcomes and complications in patients with central metastasis based on the treatment modalities, namely, MRS vs SRT/SRS

From: Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts

 

Overall

MRS

SRT/SRS

p

Muscle strength (BMRC)*

    

 Arm

4.5

4.1

4.7

n.s.

 Leg

4.6

4.4

4.8

n.s.

Patients with motor improvements (%)

44.8%

54.2%

16.7%

<0.042

Motoric Improvement (BMRC)*

    

 Arm

 

0.5

0.1

n.s.

 Leg

 

0.4

0.0

<0.05

Motoric Deterioration

10.7%

11.1%

5.1%

0.1

Dexamethasone daily dose (mg)

 

4.5

9.5

<0.001

Overall complications

31.9%

25.9%

35.7%

n.s.

 Local

13%

18.5%

9.5%

n.s.

 Systemic

18.8%

7.4%

26.2%

<0.06

  1. SRT/SRS Stereotactic radiotherapy or radiosurgery, MRS Microsurgery, BMRC British Medical Research Council, n.s not significant
  2. * mean value